Fulcrum Therapeutics Inc (FULC)
R&D Expense Growth
-11.64%
Quarterly · Period ending:
FULC R&D Expense Growth
Latest reported-11.64%period ending
Latest reported-11.64%period ending
FULC Quarterly R&D Growth (QoQ) (0.00% → -11.64%)
Latest values, visible window
High-resolution chart · PNG
FULC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -11.6444% | |
| -8.6404% | |
| 7.8344% | |
| 10.0793% | |
| -3.111% | |
| 18.1594% | |
| -22.5084% | |
| -15.1903% | |
| -10.537% | |
| 1.5527% | |
| 4.1726% | |
| 2.1794% | |
| 6.7843% | |
| -9.9698% | |
| 20.8252% | |
| -38.5827% | |
| 40.3118% | |
| -5.7159% | |
| 10.7454% | |
| -1.7321% | |
| 6.3916% | |
| 1.1706% | |
| 3.2289% | |
| 22.4266% | |
| -11.787% | |
| 25.1902% | |
| -14.2857% | |
| 24.2726% | |
| -68.639% | |
| 404.7959% | |
| -1.4792% | |
| 20.3006% | |
| 3.8579% | |
| 0% |